Annual Report

Overview

The report describes FY 2021-22 performance across Fermenta Biotech Limited and its subsidiaries, including consolidated total revenue of ₹40,665.16 Lakhs. It highlights the launch of Vitamin AD2, patented enzymatic Molnupiravir technology and green-chemistry applications. Human-capital disclosures report 604 employees, while CSR spending reached ₹189.60 Lakhs and initiatives covered health, education, veterans and wildlife. The report also details environmental programs involving water reuse, waste recycling, energy efficiency and emissions reduction.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2021-2022
Period: Ends 31 March 2022
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services